R ectal cancer is expected to account for ≈43,000 newly diagnosed cancer cases in the United States in 2018. 1 Currently, the advanced rectal cancer standard of care is a multimodal approach that entails neoadjuvant therapy and surgery. 2, 3 Surgical excision of the rectum is complex because of its proximity to genitourinary organs and the bony confines of the pelvis, which present challenges to achieving good oncologic outcomes while minimizing morbidity. 4, 5 Although advances in rectal cancer management, such as total mesorectal excision, have improved oncologic and quality-of-life outcomes for patients with rectal cancer, 6 -10 the average 5-year survival rate is only 66%. 11 Determining factors that affect rectal cancer surgery outcomes is essential to improving morbidity and mortality in patients with rectal cancer.
In particular, it has been postulated that surgeons and hospitals that treat a high volume of patients with rectal cancer have better rectal cancer surgery outcomes. 12, 13 High-volume, subspecialty-trained surgeons have better outcomes based on their training, volume, and experience, whereas high-volume hospitals achieve superior outcomes based on available resources and multidisciplinary care. 13 Nevertheless, previous reviews analyzing the association between hospital volume and rectal cancer surgery outcomes have been inconsistent. [13] [14] [15] These reviews included studies that had patients treated for rectal cancer between 1990 and the early 2000s. [13] [14] [15] Given the widespread use of technically complex total mesorectal excision and advances in rectal cancer management, such as sphincterpreserving surgery and neoadjuvant therapy since 2000, it is essential to evaluate the effects of surgeon and hospital volumes on patient outcomes based on current surgical practice. Hence, the purpose of this meta-analysis is to estimate the strength of the association between hospital/ surgeon volume and outcomes in patients with rectal cancer who received surgery since 2000.
MATERIALS AND METHODS

Search Strategy
Boolean logic was used to retrieve relevant PubMed and EMBASE English articles including data that were first collected starting in 2000 using the following key words: colorectal cancer or rectal/rectum cancer and surgery and hospital volume or surgeon volume or hospital caseload or surgeon caseload or hospital workload or surgeon workload or surgical volume or surgical caseload or surgical workload and treatment outcomes or treatment failure or adverse or surgical complications or intraoperative complications or postoperative complications or stoma or quality of healthcare or length of stay or recurrence or mortality or survival. Relevant articles were retrieved from references found from PubMed and EMBASE articles. The literature search was performed on December 29, 2017.
Article titles and abstracts that were identified from the literature using the above search strategy were uploaded to Endnote; no duplicates were found. The eligibility of research articles was assessed by 4 reviewers (C.C., J.S., N.D.V., and M.E.C.). Two reviewers were involved in the data abstraction process (C.C. and N.D.V.). Disagreements pertaining to the eligibility of articles or data abstraction were resolved via discussion.
Inclusion and Exclusion Criteria
This systematic literature review included studies that reported results based on original data analyzing the association between hospital or surgeon volume and rectal cancer outcomes in patients treated since 2000. We included articles that included patients with cancer of the rectum or rectosigmoid junction; this information was based on the International Classification of Diseases, 9th Revision codes or tumor location information. The articles had to have information about rectal cancer surgery, hospital or surgeon volume, and patient outcomes after surgery. Studies that delineated between colon and rectal cancers were included in the analysis. Articles that were based on single institutions or had 1 hospital/surgeon volume level were excluded from the study because they did not compare outcomes across hospital/surgeon volume levels. Only English language, peer-reviewed literature found in PubMed or EMBASE were reviewed to reduce bias because authors were unable to translate the Chinese articles. For additional information, some authors were contacted.
Measures and Outcomes
Hospital and surgeon volumes were the primary exposures of interest. Hospital volume was defined as the mean or number of rectal and/or rectosigmoid resections (ie, low anterior resection and abdominoperineal resection) per year or over the study period in a specific hospital. Surgeon volume was defined as either the mean or number of resections performed by a surgeon per year or over the study period. Hospital and surgeon volume categorizations were based on the definitions from the original articles. Similar to previous studies, we compared the differences between the lowest-and highest-volume groups when hospital or surgeon volume was not a dichotomous outcome. 13 The outcomes of interest in this study were surgical morbidity, postoperative mortality, surgical margin positivity, permanent colostomy rates, recurrence, and overall survival. Surgical morbidity included conditions such as anastomic leakage, abscess, iatrogenic complications, bleeding, peritonitis, stoma necrosis, stoma fistula, and wound dehiscence; the definition of surgical morbidity varied across the studies. Postoperative mortality was defined as death within 30 days of surgery. Follow-up time after rectal cancer surgery for articles that reported overall survival was defined as 1, 3, or 5 years. 
Data Extraction
An evidence grid (Table 1 ) was constructed to characterize study population characteristics (age, cancer stage, and type of surgery), sample size, study type, and study results. Statistical significance from the articles was reported for effect sizes regardless of level of significance; in the presence of both bivariate and multivariate analyses, we reported multivariate effect sizes.
Analysis
Review Manager 5
16 was used to perform the meta-analysis. A meta-analysis was performed when >2 studies reported on an outcome. When multiple studies used the same patient population, we selected only the study with the most years of data for inclusion in the pooled analysis. A random-effects model was used to perform a metaanalysis using statistically adjusted data from the included studies. 17 The meta-analysis used the natural logarithm of adjusted ORs that were extracted from the original articles, whereas the natural logarithm of SEs was derived from the extracted CIs. Heterogeneity between studies was assessed using the I 2 statistic. 18 Risk of bias was assessed using the Newcastle-Ottawa scale for observational studies 19 ; this was assessed by 4 reviewers (C.C., J.S., N.D.V., and M.E.C.). Funnel plots were used to evaluate publication bias. We stratified the analyses by the following factors: study location and type of outcome (ie, surgical morbidity was stratified by articles reporting anastomic leak only versus studies that include anastomic leaks and other type of complications).
RESULTS
Description of Included Studies
The search strategy yielded 2845 potentially relevant articles from PubMed (n = 2745) and EMBASE (n = 100; Fig. 1 ). Of the 2866 articles that were screened for eligibility based on the title, 2820 were excluded, and an additional 121 articles were excluded after reading the abstract. There were 21 additional articles that were retrieved from the references of the remaining eligible articles (n = 24); hence, a total of 35 full articles were read to determine eligibility. On reading the full articles, 14 more articles were excluded because they did not meet the inclusion and exclusion criteria. Hence, a total of 21 articles were included in the meta-analysis. The types of surgeries reported in decreasing order in the majority of articles were low anterior resection and abdominoperineal resection.
Risk of Bias Assessment
Based on the Newcastle-Ottawa scale, the studies included were generally high-quality studies (Fig. 2) . All of the articles had an adequate selection of nonexposed cohorts, demonstrated that the outcome was not present before the beginning of the study, and had study populations that were generally representative of rectal cancer patient demographics and disease stage. Of the 21 studies, only 3 studies did not have adequate follow-up time or had minimal loss to follow-up. 27, 29, 38 Although all of the studies included in the meta-analysis adjusted for potential confounders, the type of variables that were adjusted for varied across the studies. In particular, 3 studies did not adjust for cancer stage, (Fig. 3) . Similar results were obtained after excluding the article by Yasunaga et al 33 to reduce heterogeneity because there is no standard neoadjuvant chemoradiation for rectal cancer and variation in types of rectal resections in Japan. Stratified analysis revealed a marginally significant association between higher hospital volume and surgical morbidity in 5 studies from non-US countries (OR = 0.85 (95% CI, 0.72-1.00); I 2 = 18%; Fig. 4A ). Yeo et al 20 did a study in the United States that suggested that higher hospital volume is significantly associated with decreased surgical morbidity (OR = 0.71 (95% CI, 0.60-0.83)). Stratified analysis by the nature of the surgical morbidity also showed that studies that incorporated anastomic leakage and other complications, such as peritonitis and bleeding, had a significant 
Postoperative Mortality
Higher hospital volume had a significantly protective association with postoperative mortality (OR = 0.62 (95% CI, 0.43-0.88); I 2 =34%; Fig. 6 ). All 3 of the studies included in this analysis excluded rectosigmoid cancers. The study by Leonard et al, 38 which measured hospital volume continuously, was excluded from this analysis because including it introduced significant heterogeneity. This study reported significant associations between hospital volume and postoperative mortality (OR = 0.99 (95% CI, 0.98-1.00)). 38 Higher hospital volume was significantly associated with decreased postoperative mortality in the United States (Baek et al 
DISCUSSION
This meta-analysis demonstrates that high hospital volume is significantly associated with lower odds of surgical morbidity, permanent colostomy, postoperative mortality, and overall survival. In particular, patients who received surgery at high-volume hospitals were 20% less likely to experience surgical complications; the strength of this association decreased in non-US countries but increased in studies not restricted to anastomic leakage only. Highervolume hospitals compared with lower-volume hospitals were 49% and 38% less likely to receive a permanent colostomy and experience postoperative mortality. Patients who received surgery at high-volume hospitals had 1% higher odds of overall survival compared with patients at low-volume hospitals. In contrast, the results of this study suggest that surgeon volume is not significantly associated with overall survival. The significance of these associations differed across strata. In particular, the variation in significance between hospital volume and surgical morbidity type (anastomic leakage versus other surgical morbidity) suggests that high volume may be beneficial in preventing specific complications. The results of this study suggest that high-volume hospitals are more likely to result in better quality-of-life outcomes because they are less likely to have patients who receive a permanent colostomy. These results could be explained by the hospital-related factors, such as availability of resources and multidisciplinary care. In addition, since previous studies have reported that patients at high-volume hospitals are more likely to receive guideline recommended care, [41] [42] [43] this could also account for better outcomes at high-volume hospitals. Similar to what has been published previously, [13] [14] [15] 44 the higher magnitude of strength in the association between hospital volume and postoperative mortality compared with the association between hospi- tal volume and overall survival suggests that volume has a more significant impact on short-term outcomes. Similar to a previous review, 14 our study did not find significant associations between surgeon volume and overall survival. In contrast, previous meta-analyses 13, 15 have found significant associations between surgeon volume and overall survival. The differences in results may be because of variation in factors, such as the study populations, study period, and types of rectal cancer resections received in those populations. In our study, the null association between surgeon volume and survival could be attributed to selection bias if low-volume surgeons are referring more complex low-lying rectal surgeries to high-volume surgeons and retaining patients with high tumors; only 1 study adjusted for tumor location 37 in this analysis. In addition, a bias toward the null is possible if specialized surgeons in less-populated areas are classified as low volume. In addition, only 3 studies were used to determine this association, hence more research is needed to determine whether surgeon volume is associated with overall survival.
The magnitude of the volume-outcome relationship was higher in US-based studies 20, 31, 32, 34 compared with non-US-based studies. 21, 22, [24] [25] [26] [27] [28] [29] 33, 35, 36, 38, 40 This is not surprising, because most non-US locations, especially in Europe, have centralized rectal cancer management centers, whereas the United States does not; US-based articles generally had lower volume compared with non-US-based articles (Table 1 ). This suggests that centralization of rectal cancer management could result in better rectal cancer care management and ultimately improve outcomes in the United States. Baek et al 32 indicated a significant association between nonmandated regionalization and improved outcomes in patients with rectal cancer in New York, strengthening the argument for regionalization of rectal cancer surgery, which has also been shown in relation to other high-risk procedures like esophagectomy and pancreatic surgery. 45 However, efforts to regionalize rectal cancer surgery in the United States should attempt to minimize the adverse effects of treatment delay and access, which can happen during the process of regionalization. 15 Given that multiple factors have an impact on outcomes, 15 we advocate for regionalization, care pathway protocolization, and improvement in guideline-recommended care as part of a multimodal method to improve rectal cancer care.
A limitation in this analysis was that the definitions of hospital and surgeon volume were heterogeneous across the studies; some studies used continuous variables, 38, 40 and the cutoff values in studies with categorical definitions of volume differed [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] 39 (Table 1 ). This introduced bias in the meta-analysis; nevertheless, the low heterogeneity in most of the analyses suggests that its impact may be minimal. In addition, there were variations in the studies based on data source, data period, geographic location, tumor location, neoadjuvant treatment, and surgical procedures used. It is imperative for future studies on rectal cancer outcomes to improve on the level of reporting on these variables and adjust or stratify their results based on these variables. However, the use of stratified analysis was able to illuminate the volume-outcome association across some strata. Only 8 of the studies accounted for clustering by surgeon or hospital. [20] [21] [22] [23] 31, 33, 38, 40 Although most studies adjusted for some potential confounders, most of them did not adjust for all confounders, which is probably because of limitations in data availability. Generally, the included studies had low heterogeneity, and the potential for publication bias was low. The inclusion of high-quality studies with low risk of bias is another strength of the study. The similarity of these results to previously published meta-analyses is a strength of this study. 13, 15 Furthermore, all of the studies were sufficiently powered to analyze the association of interest, and patients were generally representative of patients with rectal cancer.
CONCLUSION
The results of this study contribute to the body of knowledge that indicate that high hospital volume is associated with better outcomes among patients with rectal cancer treated since 2000. Future research should determine how hospital and surgeon characteristics contribute to better outcomes in patients with rectal cancer who receive surgery. As rectal cancer treatment becomes more complex, initiatives to reduce variation in outcomes by hospital and surgeon volume in countries such as the United States are essential.
